Illumina Viral Surveillance Panel Kits for use with Government-Owned Illumina MiSeq Systems
Closed Pre-Solicitation Posted
- Solicitation number
- W81K0225QA074
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- 6640 Laboratory Equipment And Supplies
- Place of performance
- Tripler Army Medical Center, Hawaii, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Medical Readiness Contracting Office - Pacific, in support of Tripler Army Medical Center in Hawaii, intends to make a sole source award to Illumina, Inc. for specific Viral Surveillance Panel Kits designed for use with Government-Owned Illumina MiSeq Systems. The procurement includes Illumina Viral Surveillance Panel v2 Kit (Sets A, B, C, and D), MiSeq Reagent Kit v3, NextSeq 1000/2000 P1 XLEAP-SBS Reagent Kits, and Illumina RNA Fast Hyb Enrichment. The statutory authority for this non-competitive procurement is FAR 13.106-1(b)(1), which allows sole-source purchases under the simplified acquisition threshold when only one source is reasonably available. The pre-solicitation notice was posted on June 6, 2025, with a response deadline of June 13, 2025. All questions and responses must be emailed to megumi.kuwada.civ@health.mil, with the understanding that this notice does not obligate the government to award a contract.
The pre-solicitation notice indicates no specific set-aside for this procurement, and it falls under NAICS code 541714 for Research and Development in Biotechnology. The procurement is specifically for the Department of the Army Medical Command, a defense agency, and targets laboratory equipment and supplies. While no specific award value or quantity is mentioned in the notice, respondents are advised to provide comprehensive and detailed information about their qualifications to supply the required products. The government emphasizes that no proprietary, classified, confidential, or sensitive information should be included in responses, and there is no obligation to acknowledge receipt of or provide feedback on submitted information. The procurement process is focused on determining whether a competitive procurement would be in the best interest of the government.
Notice text
The Medical Readiness Contracting Office – Pacific, in support of Tripler Army Medical Center, Hawaii, intends to make a sole source award to Illumina, Inc. for the purchase of the following Viral Surveillance Panel Kits for use with Government-Owned Illumina MiSeq Systems: Illumina Viral Surveillance Panel v2 Kit, Sets A, B, C, and D; MiSeq Reagent Kit v3; NextSeq 1000/2000 P1 XLEAP-SBS Reagent Kits; Illumina RNA Fast Hyb Enrichment. The statutory authority permitting this award without providing full and open competition is FAR 13.106-1(b)(1) which authorizes the government for purchases not exceeding the simplified acquisition threshold (SAT), to solicit from one source if the Contracting Officer determines that the circumstances of the contract action deem only one source reasonably available. The NAICS code is 541714. This announcement fulfills the synopsis requirements under FAR 5.201 and 5.203. This Notice of Intent is not a request for competitive quotes. Information received in response to this notice will be considered solely for the purpose of determining whether a competitive procurement is in the best interest of the Government. All questions and responses concerning this notice shall be emailed to megumi.kuwada.civ@health.mil.
Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to supply the required products. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. No proprietary, classified, confidential, or sensitive information should be included in your response.
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity